EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology

Upcoming congress
EAACI
Hybrid Congress 2022

1 - 3 July 2022

UPCOMING EVENTS

    PAAM Digital 2021, Pediatric Allergy and Asthma Meeting
    12 - 13 November 2021
    Digital Event
    Winter School on Basic Immunology Research in Allergy and Clinical Immunology Hybrid 2022
    27 - 30 January 2022
    Semmering, Austria



Access all our previous articles
& newsletters in PDF format.
We have the honour and pleasure to invite our colleagues to contribute to the scientific programme of the EAACI Hybrid Congress 2022 to be held in Prague, Czech Republic, ...
On this World Food Day 2021, EAACI wants to raise awareness of the burden of food allergy and the importance of creating solid plans for its prevention, diagnosis and care. Mo...
We are glad to announce that the EAACI Pediatric Allergy and Asthma Meeting (PAAM Digital 2021) has been granted 16 European CME credits (ECMEC®s) by the European Accreditation Co...
We would like to warmly invite you to register for the upcoming one-day Meeting of the AllergoOncology Working Group “Danger Signals, Inflammation in Allergy and Cancer” whic...
EAACI and Allergopharma are pleased to announce the opening of applications for the EAACI – Allergopharma Research Award 2022.Apply now until November 17, 2021.The award recognis...
EAACI is pleased to announce the opening of the application period for the EAACI Research and Clinical Fellowships 2022.Applications are open until November 17, 2021. The EAACI Res...
We invite you to read the ERS/EAACI statement on Adherence to International Adult Asthma Guidelines, taken from the ERS Congress pre-event programme. This presentation recites the ...
EAACI supports medical professionals from the beginning of their studies and throughout their professional careers. Here you can find a selection of job opportunities.Consulta...
Next
We are proud to announce the launch of the new EAACI Guidelines on Omalizumab for the treatment of Chronic Spontaneous Urticaria, a major scientific output of 2021 for the Academy....
In 2019, the EAACI Working Group on Primary Care invited EAACI members to work with us to identify the needs of European general medical practitioners (GPs) with regards to allergi...
Rational use of antibiotics has become an essential topic in clinical care, mainly because of emerging antimicrobial resistance which is a threat to global health. Patients with al...
The National Allergy Societies Junior Committee (NAS-JM) is a shared platform promoted by the EAACI National Allergy Societies Committee and Junior Member Assembly to increase the ...
With more than 350 million patients affected around the world, asthma prevalence and impact are on the rise, associated with environmental and lifestyle changes. Asthma is the mo...
Aligned with the current effort of the scientific community towards higher  democratization of knowledge through the Open Access publishing model, EAACI and its partner publis...
On the International Day of Immunology, the European Academy of Allergy and Clinical Immunology would like to highlight three important topics revolving around current immunology r...
EAACI Advocacy - World Day for Safety and Health at Work: every effort should be made to keep the workplace safe and healthy On the occasion of World Day for Safety and Health at ...
Previous
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel